[Detection of multiple colon and rectal tumors during diagnostic treatment and follow-up]

Magy Onkol. 2011 Nov;55(4):244-9. Epub 2011 Jun 9.
[Article in Hungarian]

Abstract

Recognition of the commonly encountered colorectal cancer (CRC) generally begins and takes place because of and based on symptoms and signs, due to the unsettled screening of this type of cancer. Sometimes, because of advanced stage cancer urgent surgical intervention could become necessary and, if this is the case, there is no time and possibility for searching for an eventual second tumor and perhaps the patient's status does not permit performing intraoperative investigations either. The incidence of multiple colon cancer is considered to be between 2.5 and 30% according to the literature. That is why one should exclude them even in the absence of pre- and intraoperative investigations and complaints. On the other hand, colonoscopy and perhaps irrigoscopy of seemingly healthy followed-up patients is mandatory. In the case of the presence of complaints/symptoms denoting impaired intestinal passage seen in a followed-up patient or during the adjuvant setting or metastatic/recurrent disease, treatment and even during hospice care we should evaluate the possibility of a second metachronous tumor. Moreover, if there is no urgency, the multidisciplinary team (oncoteam) should recommend the adequate treatment by balancing gain/utility and risk.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adenocarcinoma / diagnosis
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / blood
  • Biopsy
  • Carcinoembryonic Antigen / blood
  • Colonic Neoplasms / diagnosis*
  • Colonic Neoplasms / epidemiology
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy
  • Colonoscopy
  • Contrast Media
  • Follow-Up Studies
  • Humans
  • Hungary / epidemiology
  • Magnetic Resonance Imaging
  • Neoplasm Staging
  • Neoplasms, Multiple Primary / diagnosis*
  • Neoplasms, Multiple Primary / epidemiology
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / therapy
  • Population Surveillance* / methods
  • Public Health
  • Rectal Neoplasms / diagnosis*
  • Rectal Neoplasms / epidemiology
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / therapy
  • Registries
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Contrast Media